Advitech is a Swiss boutique advisory firm focused on Healthcare and Fine Chemical Industry.
Combining the classic features of the purest entrepreneurial spirit with best practices of professional organizations while maintaining the highest standards of integrity, Advitech gives its clients privileged access to key market players, from Big Pharma and Large Cap Biotech to Clinical Stage Companies and Startups.
The goal? To develop and foster a successful, solid growth trajectory in the client’s functional industry.
The team offers more than 100 years of professional experience in the API (Active Pharmaceutical Ingredient) and Pharmaceutical Industry, with a strong background of credibility, unique networking and solid long term strategic vision.
Members of the team are directly involved on the Board of the Drug, Chemical & Associated Technologies Association (DCAT) in the USA.
The Advisory Areas
Advitech offers the unrivalled expertise of its team to Healthcare Industry players and financial sponsors or advisors, in order to provide exclusive, customized to the client, complete and sustained support to the implementation and expansion of a long term business strategy.
Its respected legacy is grounded on close connections with a dedicated, affiliated group of companies.
The advisory areas in which Advitech is focused are:
- CORPORATE BUSINESS DEVELOPMENT
- MANAGEMENT CONSULTING & BUSINESS INTELLIGENCE
- PRODUCTS TECHNOLOGIES PORTFOLIO MANAGEMENT
Corporate Business Development
Given the extensive and unique expertise within the private equity and financial environment, Advitech is able to assist its clients on the “Buy” as well as “Sell” side for:
- ● Strategic options evaluations
- ● M&A Projects
- ● Business Due Diligence
Management Consulting & Business Intelligence
Thanks to an unparalleled experience of his team, Advitech can assist in:
BUSINESS MODEL REVIEW
BUSINESS STRATEGY IMPLEMENTATION
Advitech's BUSINESS INTELLIGENCE activities can comfort enterprises to support a wide range of business decisions - ranging from operational to strategic:
- Internal and external firm's SWOT analyses
- Competition Landscaping
- Portfolio Evaluation
- Detection of opportunities for Innovation
- Internal Benchmarking studies
- APIsTRENDS – a collection of reports focused on the active pharmaceutical ingredients world (apistrends.advitechswiss.com)
Product & Technologies
Advitech selects and develops early stage products for its own proprietary portfolio.
Its development strategy is based on:
High Innovation degree aiming at providing significant improvement in performance, achieved through consistent, focused and synergic efforts
Intellectual property generation with the clear scope of creating added value products protected by an adequate patent coverage
Holistic project management enabling a marketing strategy developed by thinking about the business as a whole
- November 2019 – Advitech at CPhI worldwide 2019 in Frankfurt. Read More…
- May 2019 – Corriere del Ticino, FIT General Assembly Meeting in Lugano. Read More…
- January/February 2019 – Chemistry Today, A word with Paolo Magri’. Read More…
- December 2018/January 2019 – Speciality Chemicals Magazine, In every challenge lies opportunity. Read More…
- November/December 2018 – Contract Pharma, Pharma future : Trends to Watch. Read More…
- December 2018 – Advitech’s new project : APIsTRENDS – a collection of reports. Read More…
- December 2018 – Advitech’s charity support activities. Read More…
- November 2018 – Paolo Magri, Senior VP Business Development at Advitech as President of DCAT Board of Directors. Read More…
- September 2018 – Advitech joined Farma Industria Ticino (FIT) as member. Read More…
November 2018 – Paolo Magri, Senior VP Business Development at Advitech as President of DCAT Board of Directors.
We are very pleased to announce that Paolo Magri, Senior Vice President, Business Development at Advitech SA, has been elected to serve as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) beginning November 1, 2018.
Under Mr. Magri’s leadership, the Board will develop and guide the organization’s strategic plan in a manner to best serve the organization’s 500+ member companies.
DCAT’s Board of Directors is also tasked with developing strategies for the organization’s flagship event, DCAT Week. Held annually in March in New York City, DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. 92% of DCAT Week attendees are high-level decision makers from around the world who come together for business development meetings, networking opportunities and education programs.
“We are pleased to have Mr. Magri as our Board President,” said DCAT Executive Director Margaret Timony. “We rely on board members to bring innovative ideas and strategies to the table so we can continue to give our members relevant, valuable experiences across all that we offer. Mr. Magri’s passion for DCAT will undoubtedly continue to make a positive impact on our organization.”
“Mr. Magri is a longtime DCAT volunteer and brings a wealth of industry expertise and energy to the organization,” said Joe Sutton, Global Director of Sourcing for Eli Lilly and Company and DCAT’s out-going Board President. “We are fortunate to have Mr. Magri’s leadership and support as we shape our strategic plan to continue to deliver value to our member companies.”
Lugano, 1 November 2018
September 2018 – Advitech joined Farma Industria Ticino (FIT) as member.
Advitech has become member of Farma Industria Ticino (FIT) last September 2018. Farma Industria Ticino, a private organization founded in 1980, is the association of chemical and pharmaceutical industries in the Swiss canton of Ticino, headquartered in Lugano.
FIT represents the greatest majority of Ticino-based companies of this specific sector.
December 2018 – Advitech’s new project : APIsTRENDS – a collection of reports.
Advitech has just launched its new project : APIsTRENDS, a collection of reports focused on the active pharmaceutical ingredients (APIs) world, to offer an original contribution to the APIs Business Community, comprising APIs producers, clients, investors and shareholders.
The first issue of the APIsTRENDS collection ,CDMO Benchmarking Report – Baseline analysis, is now available at apistrends.advitechswiss.com to provide a benchmarking study for the CDMO sector , starting with a baseline analysis referred to 2016 data.
December 2018 – Advitech’s charity support activities .
Advitech this year supported:
ARGHOSHA FARAWAY SCHOOLS
bringing education in the remotest areas of Afghanistan since 2005
FONDAZIONE PIME ONLUS
a missionary center since 1850 focused on international cooperations, adoptions and humanitarians actions as primary care in rural areas in Bangladesh
November/December 2018 – Contract Pharma .
Pharma future : Trends to Watch
DCAT President discusses evolving pharma product mix and industry implications.
December 2018/January 2019 – Speciality Chemicals Magazine.
In every challenge lies opportunity
Paolo Magri’, Senior Vice President Business Development at Advitech Advisory and Technologies and President of the Drug, Chemical and Associated Technologies Association (DCAT), shares his thoughts on the challenges and opportunities facing the pharmaceutical industry and related trends in drug development and manufacturing.
January/February 2019 – Chemistry Today.
A word with Paolo Magri’ – President at DCAT (Drug, Chemical and Associated Technologies Association)
Paolo Magri’ shared his thoughts on trends in the fine-chemicals sector, including specialized manufacturing technologies and the future of a one-stop-shop business model with Chemistry Today.
May 22nd 2019 – Corriere del Ticino.
FIT Farma Industria Ticino General Assembly Meeting in Lugano.
FIT Farma Industria Ticino (the association of chemical and pharmaceutical industries in the Swiss canton of Ticino) General Assembly Meeting in Lugano. A strong growth of the pharmaceutical industry in the Ticino economy.
November 2019 – Advitech at CPhI worldwide 2019 in Frankfurt.
6 November PHARMA INSIGHT BRIEFINGS
Advitech shared its new project CDMO Benchmarking Report – A trend analysis 2016/2018 with all contacts and friends at CPhI WW 2019.
Thanks to all the attendees for the interest and support.
Advitech Advisory and Technologies SA
Avenue de Rhodanie 58
CH-1007 Lausanne - Switzerland
T +41 (0)21 2130270
Via degli Albrizzi 1
CH-6900 Lugano - Switzerland